Opening: Examination report scenario
▎A Real Consultation
Last month, a 42-year-old patient came to me with a thick stack of examination reports. AMH 0.43, FSH 18.6, antral follicles 1-2 on each side. She had visited three "overseas IVF service agencies," and each recommended a different hospital—one said Thailand was best, another claimed Japan had the most advanced technology, and another recommended Georgia for its cost-effectiveness. She asked me: "Which of these hospitals is actually legitimate?"
On the surface, this question is asking for a recommendation, but in reality, it is asking: What criteria should be used to determine whether an overseas IVF hospital is legitimate?
1. Determining if an Overseas IVF Hospital is Legitimate: 5 Core Criteria
To directly answer the opening question. Determining whether an overseas IVF hospital is legitimate is not about the scale of advertising or the claims of intermediaries, but about examining the following five dimensions, all of which are indispensable:
- Practice License — An assisted reproductive practice license issued by the health department of the host country, with a verifiable number through official channels.
- Laboratory Accreditation — Whether the embryology laboratory holds internationally recognized quality accreditations (CAP, JCI, or ISO 15189).
- Medical Team — Full-time reproductive endocrinology specialists who personally oversee the critical stages of stimulation protocols, egg retrieval, and embryo transfer.
- Data Transparency — Publishes real pregnancy or live birth rates stratified by age and cause, with data traceable to national registries.
- Contract Standardization — Clear fee breakdown including all items, no hidden clauses, and reasonable refund policies.
These five criteria are rigid thresholds. If any one is not met, re-evaluation is necessary. Each is explained in detail below.
Module I: Practical Process2. Practical Process for Choosing an Overseas IVF Hospital
From needs analysis to final hospital selection, it is recommended to follow these steps, each with clear verification points:
- Define Your Medical Profile: Age, AMH, FSH, obstetric history, genetic disease requirements, and willingness to accept egg/sperm donation. These determine the type of hospital suitable for you.
- Select Target Country: Understand the country's assisted reproductive laws (e.g., PGT allowed, egg source restrictions), regulatory system, visa convenience, and language support.
- Verify Hospital Credentials: Check the practice license number via the country's health department website or professional societies (e.g., US CDC, Japan JSRM, Thailand Ministry of Health).
- Confirm the Medical Team: Request the name, qualifications, and years of experience of the lead physician, and confirm that this doctor will manage your entire cycle.
- Review Data and Contracts: Request clinical pregnancy/live birth rates for the past 2-3 years stratified by age, and scrutinize the fee breakdown and contract terms item by item.
- Schedule Initial Consultation and Tests: A legitimate hospital will require a basic fertility assessment (AMH, antral follicle count, semen analysis, karyotype, etc.) before developing a personalized plan.
▎Key Reminder: Be highly cautious of any agency that skips the above steps and directly recommends a "package deal" requiring full payment. Legitimate hospitals do not lock in a fee plan without completing a medical evaluation.
3. From a Reproductive Doctor's Perspective: Core Features of a Legitimate Hospital
Over the years in practice, I have worked with dozens of reproductive centers worldwide. From a doctor's viewpoint, the most essential feature of a legitimate hospital is not luxurious facilities, but prioritizing medical indications over commercial interests. This is reflected in:
- Not promising a "high success rate" to a patient with AMH 0.2, but providing realistic egg retrieval expectations and alternatives (e.g., donor eggs).
- Not recommending unnecessary technical procedures (e.g., non-essential PGT-A or assisted hatching).
- The doctor personally reviews images, performs vaginal ultrasounds for follicle monitoring, rather than delegating entirely to junior doctors or nurses.
- For complex cases (e.g., recurrent implantation failure, endometriosis), organizing multidisciplinary discussions instead of applying standard protocols.
Quote from a Japanese reproductive doctor: "We do not use the same stimulation protocol for every patient. Being legitimate means your case is treated as a unique medical problem, not a part on an assembly line."
4. Regulatory Differences and Hospital Characteristics Across Countries
Different countries have varying regulatory systems for assisted reproduction, directly affecting the criteria for determining hospital legitimacy. Below is a comparison of four major target countries:
| Country | Regulatory Body / Certification System | Core Characteristics | Cost Reference (Per Cycle) |
|---|---|---|---|
| United States | FDA + ASRM + CDC Mandatory Data Reporting | High proportion of CAP-accredited labs, highest data transparency globally, robust legal system | $20,000 – $40,000 |
| Japan | Japan Society for Reproductive Medicine (JSRM) Certification | High precision in embryo manipulation, suitable for advanced age and repeated failure patients; higher language barrier | ¥3,000,000 – ¥5,000,000 |
| Thailand | Thai Ministry of Health + Some hospitals JCI-accredited | Wide variation in quality; focus on verifying lab accreditation; some hospitals offer Chinese language services | $8,000 – $15,000 |
| Spain | Ministry of Health Authorization + ESHRE Standards | High European standards, extensive PGT experience, legal egg donation with strict screening | €6,000 – €12,000 |
When choosing a country, consider not only cost but also laws regarding embryo genetic testing, egg source restrictions, and the number of embryos transferred. For example, some US states allow embryo sex selection, while Japan and Spain have strict restrictions.
Module F: Differences Between Hospitals5. Key Differences Between Hospitals Within the Same Country
Even within the same country, the actual quality of different hospitals can vary significantly. The following hard indicators can help distinguish them:
- Embryology Lab Level: Whether equipped with time-lapse systems, AI embryo assessment software, independent air purification and temperature control systems.
- PGT Technical Capability: Whether PGT-A, PGT-M, PGT-SR are performed in-house or outsourced. Outsourcing increases cycle time and embryo freeze-thaw risks.
- Egg Freezing and Survival Rates: Legitimate hospitals publish egg freezing survival and thaw rates, which should generally be ≥90%.
- Live Birth Rate per Single Transfer: Note whether data is stratified by age and embryo type (fresh/frozen, euploid/aneuploid).
- Physician Stability: Whether doctors frequently change. Some institutions advertise renowned doctors, but the actual treating physician may be different.
6. 5 Most Easily Overlooked Details
Over years of practice, I have noticed that many people focus on reputation, cost, and even facilities when choosing a hospital, but miss the following key points:
- Who performs the egg retrieval and transfer? — Some hospitals advertise senior experts, but the actual retrieval is done by residents, with the lead doctor only reviewing reports.
- Is the lab accreditation still valid? — CAP and JCI certifications have renewal cycles. Be wary of labs with expired or unrenewed certifications.
- Medical background of interpreters — If communicating through an interpreter, do they have basic reproductive medicine knowledge? Misinterpreting medical advice can lead to protocol deviations.
- Emergency handling mechanism — Does the hospital have a 24-hour emergency contact? How are cases of ovarian hyperstimulation or ectopic pregnancy managed?
- Requirement for complete testing — Legitimate hospitals require karyotype, semen analysis, hysteroscopy reports, etc., rather than starting a cycle based only on basic sex hormones.
7. What Lies Behind Cost Differences
The cost of overseas IVF ranges from tens of thousands to hundreds of thousands, primarily due to the following six factors:
| Cost Item | Influencing Factors | Explanation |
|---|---|---|
| Hospital Base Fee | Lab accreditation level, hospital operating costs | Operating costs for CAP-accredited labs are typically higher than for non-accredited labs |
| Physician Fee | Physician seniority, whether a renowned expert | Fees for senior reproductive doctors (20+ years experience) are usually 1.5–2 times those of junior doctors |
| Technology Surcharge | PGT, ICSI, AI embryo assessment, Time-lapse | PGT-A costs approximately $500–$1,500 per embryo; PGT-M is more expensive |
| Medication Costs | Protocol type (imported/domestic), duration of medication | Imported stimulation drugs (e.g., Gonal-F) cost about 2–3 times more than domestic ones |
| Translation & Coordination Fee | Depth of service, whether includes medical accompaniment | Professional medical translation costs more than general translation |
| Additional Tests & Freezing Fees | Hysteroscopy, chromosome testing, annual embryo freezing fee | Some hospitals charge freezing fees annually; confirm in advance |
Legitimate hospitals provide a detailed fee schedule and confirm all potential additional costs before treatment begins. If a hospital cannot provide a written cost breakdown or only offers a "package price" without specifying what is included, proceed with caution.
Module Q: Frequently Asked Questions8. Frequently Asked Questions and Answers
Below are answers to questions repeatedly asked during consultations:
Q1: How can I check if a foreign hospital is legitimate?
A: Check via the country's health department website or professional society. For example, in the US, check the CDC ART database; in Japan, the JSRM member directory; in Thailand, the Ministry of Health medical license database. Enter the hospital name or license number.
Q2: How far in advance should I prepare for overseas IVF?
A: Generally, 3–6 months in advance. You need to complete a basic fertility assessment (AMH, FSH, antral follicle count, semen analysis), karyotype, infectious disease screening, hysteroscopy (if necessary), and obtain a passport and visa. Some test results have limited validity (e.g., infectious disease screening for 6 months), so schedule retesting according to your cycle timeline.
Q3: Can I still do overseas IVF with very low AMH?
A: Yes, but you need to choose an experienced hospital and doctor. Low AMH means low ovarian reserve, requiring individualized mild stimulation or natural cycle protocols, not standard long protocols. A legitimate hospital will assess expected egg yield based on AMH, FSH, and antral follicle count and provide realistic advice—including whether to consider egg donation.
Q4: Does the male partner need to accompany throughout the overseas IVF process?
A: No, full accompaniment is not required. The male partner typically needs to be at the hospital on the day of egg retrieval to provide a semen sample. If using frozen sperm, the sample can be frozen before the cycle starts. However, the male partner must complete semen analysis, infectious disease screening, and chromosome testing (if necessary).
Q5: Will a legitimate hospital guarantee success?
A: No. Any institution that promises "guaranteed success" or "100% pregnancy" is not legitimate. IVF success rates are influenced by age, ovarian function, embryo quality, uterine environment, and other factors. A legitimate hospital provides data-based realistic expectations, not promises.
▎Related Tests and Process Entities: AMH · FSH · LH · Antral Follicle Count · Semen Analysis · Karyotype · Genetic Counseling · Hysteroscopy · Ovarian Stimulation · Egg Retrieval · Embryo Culture · PGT-A/PGT-M · Frozen Embryo Transfer · Luteal Support · Reproductive Doctor · Embryology Lab · Passport · Visa · Medical Record
Ending: Risk Reminder⚠️ Risk Reminder
Overseas IVF involves cross-border medical care, different legal systems, and language barriers, carrying the following potential risks:
- Legal protections for assisted reproduction may be inadequate in some countries/regions, leading to high dispute resolution costs.
- Laboratory standards vary; some institutions have expired or unaccredited international certifications.
- Translation errors can lead to misunderstandings of protocols, affecting treatment outcomes.
- Risk of cost overruns—some hospitals add extra items during treatment without prior notice.
It is recommended to complete at least three steps—credential verification, data comparison, and contract review—before finalizing a hospital, and keep all written communication records. If necessary, consult an independent advisor with a background in reproductive medicine to avoid making decisions solely based on intermediary recommendations.
Suggested Next Steps: After completing the five-criteria verification described in this article, select 2–3 qualified hospitals for an online initial consultation or video appointment. Communicate directly with the lead physician about your test reports and treatment plan. During the consultation, observe whether the doctor fully answers your questions and offers alternative options—this is also an important reference for judging hospital legitimacy.
Comments (0)